Dosimetry study of 3D-printed noncoplanar template-assisted CT-guided 125I seed implantation for the treatment of recurrent and metastatic tumors in the head and neck
PLOS One · 2025
DOI: 10.1371/journal.pone.0330271 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Lingyun Qiu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangz…. Hauptthemen laut MEDLINE: Iodine Radioisotopes, Head and Neck Neoplasms, Printing, Three-Dimensional, Tomography, X-Ray Computed. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Technology and Education of Zhejiang Province of China.
Abstract (Originalsprache)
Objective
Recurrent and metastatic tumors of the head and neck pose significant treatment challenges due to their proximity to critical structures and prior radiation exposure. This study aimed to evaluate the consistency between preoperative and postoperative dosimetric parameters in CT-guided 3 D-printed noncoplanar template (3DPNCT)-assisted radioactive iodine-125 seed implantation (RISI).
Methods
Twenty-six patients with recurrent or metastatic head and neck cancer were retrospectively analyzed. Gross tumor volume (GTV) coverage and dosimetric parameters such as D90 (dose covering 90% of the GTV), conformity index (CI), and homogeneity index (HI) were compared before and after implantation. The Shapiro-Wilk test was used to assess data normality.
Results
There were no significant differences between pre- and postoperative D90, V100, V150, or CI values (P > 0.05). Bland–Altman analysis showed high agreement for key metrics.
Conclusions
3DPNCT-assisted RISI demonstrated accurate dose delivery and high reproducibility. This approach may enhance local control while minimizing radiation to organs at risk in complex head and neck anatomies. These results suggest that this technique has promising clinical applicability in complex head and neck cases; however, further validation through larger prospective studies is warranted to confirm long-term efficacy and safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
- Department of Breast Surgery, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang, China.
- School of Medical Technology, Yunnan Engineering Vocational College, Yunnan, China.
- Radiotherapy and Chemotherapy Center, First Affiliated Hospital of Ningbo University, Ningbo, China.
ORCID-Profile: Lingyun Qiu, Kainan Shao
Förderung
- Medical Technology and Education of Zhejiang Province of China
Zitieren
APA
Qiu, L., Wu, R., Chen, Y., Xiang, H., Zhan, W., Zhang, Y., Li, Q., Liu, H., Ding, J., Li, Y., Bi, A., Luo, L., Jia, Y., Chen, W., & Shao, K. (2025). Dosimetry study of 3D-printed noncoplanar template-assisted CT-guided 125I seed implantation for the treatment of recurrent and metastatic tumors in the head and neck. PLOS One. https://doi.org/10.1371/journal.pone.0330271
Vancouver
Qiu L, Wu R, Chen Y, Xiang H, Zhan W, Zhang Y, et al. Dosimetry study of 3D-printed noncoplanar template-assisted CT-guided 125I seed implantation for the treatment of recurrent and metastatic tumors in the head and neck. PLOS One. 2025. doi:10.1371/journal.pone.0330271
BibTeX
@article{Qiu2025,
author = {Qiu, Lingyun and Wu, Rong and Chen, Yinan and Xiang, Haixin and Zhan, Wenming and Zhang, Yinghao and Li, Qiang and Liu, Huaxin and Ding, Jieni and Li, Yucheng and Bi, Aihong and Luo, Limin and Jia, Yongshi and Chen, Weijun and Shao, Kainan},
title = {Dosimetry study of 3D-printed noncoplanar template-assisted CT-guided 125I seed implantation for the treatment of recurrent and metastatic tumors in the head and neck},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0330271}
}
EUVIMED